The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty

Cardiovascular Research

Volumn 30, Issue 1, 1995, Pages 87-96

  Groves, Peter H ^a   Banning, Adrian P ^a   Penny, William J ^a   Newby, Andrew C ^a   Cheadle, Hilary A ^a   Lewis, Malcolm J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Arteries; Molsidomine; Pig; Platelets; Restenosis; SIN 1; Smooth muscle cell proliferation

Indexed keywords

CYCLINE; LINSIDOMINE; MOLSIDOMINE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; VASCULAR SMOOTH MUSCLE;

ANGIOPLASTY, BALLOON; ANIMAL; CAROTID ARTERIES; CELL DIVISION; MOLSIDOMINE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; PLATELET ADHESIVENESS; POSTOPERATIVE PERIOD; SUPPORT, NON-U.S. GOV'T; SWINE;

EID: 0029089385     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1016/S0008-6363(95)00009-7     Document Type: Article

References (42)

1. Kaltenbach M, Kober G, Scherer D Vallbracht C. Recurrence rate after successful angioplasty. Eur Heart J 1985;6:276–281.
2. Nobuyoshi M, Kimura T, Nosaka H, et al, Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow up of 229 patients. J Am Coll Cardiol 1988;12:616–623.
3. Popma JJ, Califf RM, Topol EJ. Clinical trials of restenosis after coronary angioplasty. Circulation 1991;84:1426–1436.
4. King SB. Role of new technology in balloon angioplasty. Circulation 1991;84:2574–2579.
5. Ellis SG, DeCesare NB, Pinkerton CA et al. Relation of stenosis morphology and clinical presentation to the procedural results of directional coronary atherectomy. Circulation 1991;84:644–653.
6. Kohchi K, Takebayashi S, Block PC, Hiroki T. Arterial changes after percutaneous coronary angioplasty:results at autopsy. J Am Coll Cardiol 1987;10:592–599.
7. Johnson DE, Hinohara T, Selmon MR, Braden LJ, Simpson JB. Primary peripheral arterial stenoses and restenosis excised by transluminal atherectomy: a histopathologic study. J Am Coll Cardiol 1990;15:419–425.
8. Clowes AW, Clowes MM, Reidy MA. Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels. Lab Invest 1986;54:295–303.
9. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor. Cell 1986;46:155–169.
10. Libby P, Warner SJC, Salomon RN, Birinye LK. Production of platelet derived growth factor-like mitogen by smooth muscle cells from human atheroma. N Engl J Med 1988;318:1493–1498.
11. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulation of T cells macrophages and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986;6:131–138.
12. Griffith TM, Lewis MJ, Newby AC, Henderson AH. Endothelium-derived relaxing factor. J Am Coll Cardiol 1988;12:797–806.
13. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;ii:1057–1058.
14. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8bromo-cyclic-guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774–1777.
15. Assender JW, Southgate KM, Newby AC. Does nitric oxide inhibit smooth muscle proliferation? J Cardiovasc Pharm 1991;17:S104–S107.
16. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Anti-atherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992;90:1168–1172.
17. McNamara DB, Bedi B, Aurora H, et al. L-Arginine inhibits balloon catheter-induced intimai hyperplasia. Biochem Biophys Res Commun 1993;193:291–296.
18. Gerzer R, Karrenbrock B, Siess W, Heim J-M. Direct comparison of the effects of nitroprusside, SIN-1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity. Thromb Res 1988;52:11–21.
19. Groves PH, Penny WJ, Cheadle HA, Lewis MJ. Exogenous nitric oxide inhibits in vivo platelet adhesion following balloon angioplasty. Cardiovasc Res 1992;26:615–619.
20. Groves PH, Lewis MJ, Cheadle HA, Penny WJ. SIN-1 reduces platelet adhesion and platelet-thrombus formation in a porcine model of balloon angioplasty. Circulation 1993;87:590–597.
21. Groves PH, Newby AC, Lewis MJ, Cheadle HA, Penny WJ. Progressive intimai thickening following balloon angioplasty is related to rupture of the internal elastic lamina. Br Heart J 1992;68:86 (Abstract).
22. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H. Cyclin (PCNA) is the auxiliary protein of DNA polymerase S. Nature 1987;326:515–518.
23. Galand P, Degraef C. Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissue. Cell Tissue Kinet 1989;22:383–392.
24. Steele PM, Chesebro JH, Stanson AW, et al. Balloon angioplasty: natural history of the pathophysiological response to injury in a pig model. Circ Res 1985;57:105–112.
25. Bonan R, Paiement P, Scortichini D, Cloutier M-J, Leung TK. Coronary restenosis: evaluation of a restenosis injury index in a swine model. Am Heart J 1993;126:1334–1340.
26. Schwartz RS, Huber KC, Murphy JG, et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992;19:167–174.
27. Mertz ET. The anomaly of a normal Duke’s and a very prolonged saline bleeding time in swine suffering from an inherited bleeding disease. Am J Physiol 1942;136:360–362.
28. Bradford MM. A rapid and sensitive method for the quantification on microgram quantities of protein utilizing the principle of protein-dye binding. Analyt Biochem 1976;72:248–254.
29. Guo J-P, Milhoan KA, Tuan RS, Lefer AM. Beneficial effect of SPM-5185, a cysteine-containing nitric oxide donor in rat carotid artery intimai injury. Circ Res 1994;75:77–84.
30. Luginbuhl H, Jones JET. The morphology and morphogenesis of atheroscleosis in aged swine. Ann NY Acad Sci 1965;127:763–779.
31. Muller DWM, Ellis SG, Topol EJ. Experimental models of coronary artery restenosis. J Am Coll Cardiol 1992;19:418–432.
32. Kukovetz WR, Holzmann S. Mechanism of vasodilatation by molsidomine. Am Heart J 1985;109:637–640.
33. Bassenge E, Zanzinger J. Effectiveness of an NO-releasing pir-sidomine derivative on coronary conductance during long-term administration. J Cardiovasc Pharm 1993;22:S22–S26.
34. Southgate K, Newby AC. Serum-induced proliferation of rabbit aortic smooth muscle cells from the contractile state is inhibited by 8-Br-cAMP but not 8-Br-cGMP. Atherosclerosis 1990;82:113–123.
35. Souness JE, Hassall GA, Parrott DP. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors. Biochem Pharmacol 1992;44:857–866.
36. Assoian RK, Sporn MB. Type β-transforming growth factor in human platelets:release during platelet degranulation and action on smooth muscle cells. J Cell Biol 1986;102:1217–1223.
37. Assoian RK, Grotendorst GR, Miller DM, Sporn MB. Cellular transformation by coordinate action of three peptide growth factors from human platelets. Nature 1984;309:804–806.
38. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against fibroblast growth factor. Proc Natl Acad Sci USA 1991;88:3739–3743.
39. Hanke H, Oberhoff M, Hanke S, et al. Inhibition of cellular proliferation after experimental balloon angioplasty by low-molecular-weight heparin. Circulation 1992;85:1548–1556.
40. Casscels W. Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation 1992;86:723–729.
41. Schwartz RS, Holmes DR Jr., Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992;20:1284–1293.
42. Mecham RP, Levy BD, Morris SL, Madaras JG, Wrenn DS. Increased cyclic GMP levels lead to a stimulation of elastin production in ligament fibroblasts that is reversed by cyclic AMP. J Biol Chem 1985;260:3255–3258.